This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2016 Aug 25;375(8):767-77.

doi: 10.1056/NEJMra1504367.

Treatment of Patients with Cirrhosis

Phillip S Ge¹, Bruce A Runyon¹

Affiliations

Affiliation

¹ From the Division of Digestive Diseases, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (P.S.G.); and the Division of Gastroenterology and Hepatology, University of New Mexico, Albuquerque, and the Indian Health Service, Northern Navajo Medical Center, Shiprock - both in New Mexico (B.A.R.).

PMID: 27557303
DOI: 10.1056/NEJMra1504367

Review

Treatment of Patients with Cirrhosis

Phillip S Ge et al. N Engl J Med. 2016.

. 2016 Aug 25;375(8):767-77.

doi: 10.1056/NEJMra1504367.

Authors

Phillip S Ge¹, Bruce A Runyon¹

Affiliation

¹ From the Division of Digestive Diseases, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (P.S.G.); and the Division of Gastroenterology and Hepatology, University of New Mexico, Albuquerque, and the Indian Health Service, Northern Navajo Medical Center, Shiprock - both in New Mexico (B.A.R.).

PMID: 27557303
DOI: 10.1056/NEJMra1504367

No abstract available

PubMed Disclaimer

Comment in

Treatment of Patients with Cirrhosis.
Qi X, De Stafano V, Guo X. Qi X, et al. N Engl J Med. 2016 Nov 24;375(21):2103-4. doi: 10.1056/NEJMc1612334. N Engl J Med. 2016. PMID: 27959722 No abstract available.
Treatment of Patients with Cirrhosis.
Kumar P, Taneja S, Singh V. Kumar P, et al. N Engl J Med. 2016 Nov 24;375(21):2102-3. doi: 10.1056/NEJMc1612334. N Engl J Med. 2016. PMID: 27959723 No abstract available.
Treatment of Patients with Cirrhosis.
Perricone G, Vangeli M, Belli LS. Perricone G, et al. N Engl J Med. 2016 Nov 24;375(21):2103. doi: 10.1056/NEJMc1612334. N Engl J Med. 2016. PMID: 27959724 No abstract available.
Treatment of Patients with Cirrhosis.
Ge PS, Runyon BA. Ge PS, et al. N Engl J Med. 2016 Nov 24;375(21):2104-5. doi: 10.1056/NEJMc1612334. N Engl J Med. 2016. PMID: 28121086 No abstract available.

Similar articles

[Pharmacological treatment of the portal hypertension].
Castañeda Romero B. Castañeda Romero B. Rev Gastroenterol Mex. 2005 Nov;70 Suppl 3:64-5. Rev Gastroenterol Mex. 2005. PMID: 17471863 Review. Spanish. No abstract available.
[Primary prevention of digestive hemorrhages in cirrhotic patients].
Calès P. Calès P. Ann Gastroenterol Hepatol (Paris). 1990 Oct;26(5):193-200. Ann Gastroenterol Hepatol (Paris). 1990. PMID: 1979480 Review. French. No abstract available.
[Primary prevention of variceal bleeding in cirrhosis].
Schepke M. Schepke M. Dtsch Med Wochenschr. 2006 Jun 2;131(22):1269-72. doi: 10.1055/s-2006-946562. Dtsch Med Wochenschr. 2006. PMID: 16755423 German. No abstract available.
Patient with cirrhosis and presumed spontaneous bacterial peritonitis.
Jones RA, Tabbut M, Shaman Z, Gramer D. Jones RA, et al. Chest. 2014 Jul;146(1):e11-e13. doi: 10.1378/chest.13-2997. Chest. 2014. PMID: 25010972 No abstract available.
[Primary prevention of esophageal varices].
Sieveking CF. Sieveking CF. Dtsch Med Wochenschr. 2006 Aug 4;131(31-32):1758; author reply 1758. doi: 10.1055/s-2006-947833. Dtsch Med Wochenschr. 2006. PMID: 16868885 German. No abstract available.

See all similar articles

Cited by

Recent insights into contributing factors in the pathogenesis of cirrhotic ascites.
Li Z, Zhu J, Ouyang H. Li Z, et al. Front Med (Lausanne). 2024 Sep 13;11:1376217. doi: 10.3389/fmed.2024.1376217. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39346937 Free PMC article. Review.
A review of Phyllanthus urinaria L. in the treatment of liver disease: viral hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinoma.
Liu L, Wang B, Ma Y, Sun K, Wang P, Li M, Dong J, Qin M, Li M, Wei C, Tan Y, He J, Guo K, Yu XA. Liu L, et al. Front Pharmacol. 2024 Aug 9;15:1443667. doi: 10.3389/fphar.2024.1443667. eCollection 2024. Front Pharmacol. 2024. PMID: 39185304 Free PMC article. Review.
Muscle mass dynamics is independently associated with long-term liver-related mortality in patients with cirrhosis.
Zheng J, Yang S, Ren W, Zhong J, Liu X, Han R, Wei T, Tie C, Yang Y, Hong C, Feng B, Huang R. Zheng J, et al. Heliyon. 2024 Aug 3;10(15):e35354. doi: 10.1016/j.heliyon.2024.e35354. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170308 Free PMC article.
Serum Cytokeratin-18 levels as a prognostic biomarker in advanced liver disease: a comprehensive meta-analysis.
Zhang X, Li J, Jiang L, Deng Y, Wei L, Li X. Zhang X, et al. Clin Exp Med. 2024 Jul 18;24(1):160. doi: 10.1007/s10238-024-01423-y. Clin Exp Med. 2024. PMID: 39023658 Free PMC article.
Evaluation of hepatic injury in chronic hepatitis B and C using APRI and FIB-4 indices compared to fibroscan results.
Najafi N, Razavi A, Jafarpour H, Raei M, Azizi Z, Davoodi L, Abdollahi A, Frouzanian M. Najafi N, et al. Ann Med Surg (Lond). 2024 May 15;86(7):3841-3846. doi: 10.1097/MS9.0000000000002095. eCollection 2024 Jul. Ann Med Surg (Lond). 2024. PMID: 38989210 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- H1 Connect
- scite Smart Citations
Medical
- MedlinePlus Health Information